• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中退化神经元中c-jun氨基末端激酶/应激激活蛋白激酶的激活与重新分布

Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.

作者信息

Zhu X, Raina A K, Rottkamp C A, Aliev G, Perry G, Boux H, Smith M A

机构信息

Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.

出版信息

J Neurochem. 2001 Jan;76(2):435-41. doi: 10.1046/j.1471-4159.2001.00046.x.

DOI:10.1046/j.1471-4159.2001.00046.x
PMID:11208906
Abstract

Cellular responses to increased oxidative stress appear to be a mechanism that contributes to the varied cytopathology of Alzheimer's disease (AD). In this regard, we suspect that c-Jun N-terminal kinase/Stress activated protein kinase (JNK/SAPK), a major cellular stress response protein induced by oxidative stress, plays an important role in Alzheimer disease in susceptible neurons facing the dilemma of proliferation or death. We found that JNK2/SAPK-alpha and JNK3/SAPK-beta were related to neurofibrillary pathology and JNK1/SAP-Kgamma related to Hirano bodies in cases of AD but were only weakly diffuse in the cytoplasm in all neurons in control cases and in non-involved neurons in diseased brain. In this regard, in hippocampal and cortical regions of individuals with severe AD, the activated phospho-JNK/SAPK was localized exclusively in association with neurofibrillar alterations including neurofibrillary tangles, senile plaque neurites, neuropil threads and granulovacuolar degeneration structures (GVD), completely overlapping with tau-positive neurofibrillary pathology, but was virtually absent in these brain regions in younger and age-matched controls without pathology. However, in control patients with some pathology, as well as in mild AD cases, there was nuclear phospho-JNK/SAPK and translocation of phospho-JNK/SAPK from nuclei to cytoplasm, respectively, indicating that the activation and re-distribution of JNK/SAPK correlates with the progress of the disease. By immunoblot analysis, phospho-JNK/SAPK is significantly increased in AD over control cases. Together, these findings suggest that JNK/SAPK dysregulation, probably resulting from oxidative stress, plays an important role in the increased phosphorylation of cytoskeletal proteins found in AD.

摘要

细胞对氧化应激增加的反应似乎是一种导致阿尔茨海默病(AD)多种细胞病理学变化的机制。在这方面,我们怀疑c-Jun氨基末端激酶/应激激活蛋白激酶(JNK/SAPK),一种由氧化应激诱导的主要细胞应激反应蛋白,在面临增殖或死亡困境的易感神经元的阿尔茨海默病中起重要作用。我们发现,在AD病例中,JNK2/SAPK-α和JNK3/SAPK-β与神经原纤维病理学相关,而JNK1/SAP-Kγ与 Hirano小体相关,但在对照病例的所有神经元以及患病大脑中未受累的神经元中,它们仅在细胞质中呈弱弥漫性分布。在这方面,在重度AD患者的海马和皮质区域,活化的磷酸化JNK/SAPK仅与包括神经原纤维缠结、老年斑神经突、神经毡线和颗粒空泡变性结构(GVD)在内的神经原纤维改变相关,与tau阳性神经原纤维病理学完全重叠,但在无病理学改变的年轻和年龄匹配对照的这些脑区中几乎不存在。然而,在有一些病理学改变的对照患者以及轻度AD病例中,分别存在核磷酸化JNK/SAPK以及磷酸化JNK/SAPK从细胞核向细胞质的转位,这表明JNK/SAPK的激活和重新分布与疾病进展相关。通过免疫印迹分析,与对照病例相比,AD中磷酸化JNK/SAPK显著增加。总之,这些发现表明,可能由氧化应激导致的JNK/SAPK失调在AD中发现的细胞骨架蛋白磷酸化增加中起重要作用。

相似文献

1
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.阿尔茨海默病中退化神经元中c-jun氨基末端激酶/应激激活蛋白激酶的激活与重新分布
J Neurochem. 2001 Jan;76(2):435-41. doi: 10.1046/j.1471-4159.2001.00046.x.
2
JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease.JKK1是JNK/SAPK的上游激活剂,在阿尔茨海默病中被激活。
J Neurochem. 2003 Apr;85(1):87-93. doi: 10.1046/j.1471-4159.2003.01645.x.
3
Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.帕金森病和路易体痴呆中活性磷酸化依赖性丝裂原活化蛋白激酶(MAPK/ERK)、应激激活蛋白激酶/c-Jun氨基末端激酶(SAPK/JNK)和p38激酶的表达
J Neural Transm (Vienna). 2001;108(12):1383-96. doi: 10.1007/s007020100015.
4
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.磷酸化丝裂原活化蛋白激酶(MAPK/ERK-P)、38 kDa蛋白激酶(p38-P)、应激激活蛋白激酶(SAPK/JNK-P)和钙/钙调蛋白依赖性激酶II(CaM激酶II)在tau蛋白病的神经元和神经胶质细胞的tau沉积物中差异表达。
J Neural Transm (Vienna). 2001;108(12):1397-415. doi: 10.1007/s007020100016.
5
Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.参与tau蛋白磷酸化的不同激酶的当前研究进展及其在阿尔茨海默病和tau蛋白病中的意义。
Curr Alzheimer Res. 2005 Jan;2(1):3-18. doi: 10.2174/1567205052772713.
6
Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.阿尔茨海默病和tau蛋白病中海马磷酸化应激激活蛋白激酶/应激活化蛋白激酶颗粒与颗粒空泡变性小体的关系。
Acta Neuropathol. 2007 Jan;113(1):63-73. doi: 10.1007/s00401-006-0159-4. Epub 2006 Nov 7.
7
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.阿尔茨海默病中神经元ERK、JNK/SAPK和p38的差异激活:“两次打击”假说
Mech Ageing Dev. 2001 Dec;123(1):39-46. doi: 10.1016/s0047-6374(01)00342-6.
8
Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.应激激活激酶c-Jun氨基末端激酶(SAPK/JNK-P)和p38激酶(p38-P)的表达,以及APP Tg2576小鼠中β淀粉样蛋白斑块周围神经突中的tau蛋白过度磷酸化。
Neuropathol Appl Neurobiol. 2004 Oct;30(5):491-502. doi: 10.1111/j.1365-2990.2004.00569.x.
9
Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.参与阿尔茨海默病、tau蛋白病及APP转基因小鼠中tau蛋白磷酸化的应激激酶。
Neurotox Res. 2004;6(6):469-75. doi: 10.1007/BF03033283.
10
c-Jun phosphorylation in Alzheimer disease.阿尔茨海默病中的c-Jun磷酸化
J Neurosci Res. 2007 Jun;85(8):1668-73. doi: 10.1002/jnr.21298.

引用本文的文献

1
Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches.阿尔茨海默病与额颞叶痴呆:病理生理学与治疗方法综述
J Neurosci Res. 2025 May;103(5):e70046. doi: 10.1002/jnr.70046.
2
Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery.神经退行性疾病中的蛋白激酶:当前认识及对药物研发的意义
Signal Transduct Target Ther. 2025 May 7;10(1):146. doi: 10.1038/s41392-025-02179-x.
3
Amyloid-β can activate JNK signalling via WNT5A-ROR2 to reduce synapse formation in Alzheimer's disease.
淀粉样蛋白β可通过WNT5A-ROR2激活JNK信号通路,以减少阿尔茨海默病中的突触形成。
J Cell Sci. 2025 Feb 1;138(3). doi: 10.1242/jcs.263526. Epub 2025 Feb 5.
4
Comparison of Neurogenesis Promotion Effects between Cinnamoylquinic Acids in Neural Stem Cells from Adult Mice Brains.成年小鼠脑内神经干细胞中肉桂酰奎宁酸促进神经发生作用的比较
ACS Chem Neurosci. 2024 Sep 30;15(20):3713-23. doi: 10.1021/acschemneuro.4c00329.
5
Exploring the Therapeutic Potential of Glycyrrhiza Compounds in Alzheimer's Disease: A Comprehensive Review.探索甘草化合物在阿尔茨海默病中的治疗潜力:一项综述
Curr Top Med Chem. 2025;25(3):286-310. doi: 10.2174/0115680266322320240911194626.
6
Unraveling the complexity of human brain: Structure, function in healthy and disease states.解析人类大脑的复杂性:健康与疾病状态下的结构和功能。
Ageing Res Rev. 2024 Sep;100:102414. doi: 10.1016/j.arr.2024.102414. Epub 2024 Jul 15.
7
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease.miRNAs 在阿尔茨海默病发病机制、诊断和治疗中的潜在意义。
Int J Mol Sci. 2023 Nov 13;24(22):16259. doi: 10.3390/ijms242216259.
8
Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review).炎症信号通路在阿尔茨海默病治疗中的抑制剂、天然产物和代谢物(综述)。
Int J Mol Med. 2023 Nov;52(5). doi: 10.3892/ijmm.2023.5314. Epub 2023 Oct 6.
9
Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.甘草查尔酮 A:治疗阿尔茨海默病的一种潜在多靶药物。
Int J Mol Sci. 2023 Sep 16;24(18):14177. doi: 10.3390/ijms241814177.
10
Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.神经元中核糖核蛋白凝聚物的相分离和病理转变:对肌萎缩侧索硬化症、额颞叶痴呆及其他神经退行性疾病的影响
Front Mol Neurosci. 2023 Sep 1;16:1242925. doi: 10.3389/fnmol.2023.1242925. eCollection 2023.